To investigate the biological function of BCL2A1 in gliomas, we screened 14 downregulated genes and 510 upregulated genes between the high and low BCL2A1 expression groups in TCGA-GBMLGG. The gene discussed is BCL2A1; the disease is central nervous system cancer.